Ambeed.cn

首页 / 抑制剂/激动剂 / 免疫/炎症 / IRAK / Zabedosertib

Zabedosertib 99%+

货号:A1388394 同义名: BAY 1834845 产品仅供科研

Zabedosertib 化学结构 CAS号:1931994-81-8
Zabedosertib 化学结构
CAS号:1931994-81-8
Zabedosertib 3D分子结构
CAS号:1931994-81-8
Zabedosertib 化学结构 CAS号:1931994-81-8
Zabedosertib 3D分子结构 CAS号:1931994-81-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Zabedosertib 纯度/质量文件

货号:A1388394 标准纯度:99%+
批次查询: 批次纯度:

全球学术期刊中引用的产品

Mar. Drugs, 2024, 22(5): 194. Ambeed. [ A104599 ]
Pharmaceuticals, 2024, 17(5): 570. Ambeed. [ A224421 ]
更多 >

Zabedosertib 生物活性

描述 Zabedosertib (BAY 1834845) is a selective, orally active IRAK4 inhibitor with an IC50 of 3.55 nM, showing immunomodulatory potential. IRAK4 is a kinase integral to signaling innate immune responses from Toll-like receptors [1]. Zabedosertib also exhibits anti-inflammatory properties against IL-β, LPS, and Imiquimod-induced inflammation [2]. Zabedosertib reduces the secretion of inflammatory cytokines such as IL-1, IFN-γ, TNF-α, and IL-17 at 500 nM [2].

Zabedosertib 动物研究

Animal study Zabedosertib (150 mg/kg, orally, twice) mitigates lung injury and diminishes inflammation in LPS-induced ARDS in BALB/c mice [2]. Zabedosertib inhibits inflammation induced by IL-β (pO., 40-80 mg/kg, once), LPS (pO., 10-40 mg/kg, once), and Imiquimod (pO., 15-150 mg/kg, twice daily for 7 days) [3]. Zabedosertib is characterized by its pharmacokinetic profile in rats [3].

Zabedosertib 参考文献

[1]Bothe, Ulrich; Siebenreicher, Holger; Schmidt, Nicole; Nubbemeyer, Reinhard; Boemer, Ulf; Guenther, Judith; Steuber, Holger; Lange, Martin; Stegmann, Christian; Sutter, Andreas; et al.New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs.WO2016083433A1

[2]Li Q, et al., Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome. Biomed Pharmacother. 2022 Sep;153:113459.

[3]Bothe U, et al., Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839. J Med Chem. 2024 Jan 25;67(2):1225-1242.

Zabedosertib 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.63mL

2.13mL

1.06mL

21.26mL

4.25mL

2.13mL

Zabedosertib 技术信息

CAS号1931994-81-8
分子式C20H21F3N4O4S
分子量470.465
别名 BAY 1834845
运输蓝冰
存储条件

粉末 Sealed in dry,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 120 mg/mL(255.07 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
客户支持
专业术语
缩略词释义
质量手册
产品咨询
计算器
活动政策
订购方法
活动声明
联系我们
400-920-2911 sales@ambeed.cn tech@ambeed.cn
Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。